Part-Time

Principal Investigator

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$200k - $400k/yr

+ 401(k) company match + Bi-weekly HSA employer contribution

No H1B Sponsorship

Brandon, FL, USA

In Person

100% of work is performed on site; occasional planned travel may be required, with less than 10% travel.

MD

Category
Biology & Biotech (1)

Get referred to Care Access

See people who can refer or advise you

Requirements
  • Excellent written and verbal communication skills.
  • Ability to effectively prioritize tasks in a fast-paced environment.
  • Attention to detail and ability to maintain confidentiality when handling sensitive information.
  • Critical thinking and dynamic problem-solving skills.
  • An MD or DO with an active, unrestricted medical license valid in the state where the research is conducted.
  • Previous experience as a Principal Investigator is required.
  • Training and certification in Good Clinical Practice is required.
  • Ability to comply with International Conference on Harmonization Good Clinical Practice and all applicable regulatory requirements.
  • Ability to use keyboards and other computer equipment.
  • Ability to work around bloodborne pathogens.
Responsibilities
  • Provide overall medical oversight and medical review of protocols in conformance with good clinical practice.
  • Review sponsor-provided safety reports.
  • Review and maintain accurate case report forms.
  • Ensure the safety and well-being of all study participants at the trial site.
  • Assess subject response to therapy and evaluate and address adverse experiences.
  • Perform physical assessments, examinations, and study procedures as required by study protocols.
  • Train Sub-Investigators and study staff members on protocol and protocol-specific procedures.
  • Provide medical support to Sub-Investigators and study staff for protocol-related issues, including protocol clarifications, inclusion/exclusion determinations, and patient safety or eligibility issues.
  • Review inclusion and exclusion criteria, endpoint criteria, and investigational product use with the internal research team.
  • Complete required Care Access and protocol-specific training.
  • Participate in monitoring visits and sponsor meetings.
  • Allow monitoring and auditing by sponsors and inspection by appropriate regulatory agencies.
Desired Qualifications
  • Two years of prior experience as a Principal Investigator or Sub-Investigator.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Texas and Georgia sites on April 29, 2026.
  • Association of Black Cardiologists partnership expands heart-health screenings and trial recruitment.
  • Brazil acquisition and Warsaw opening extend Care Access's footprint into two new geographies.

What critics are saying

  • Walmart becomes a single-channel dependency if store rollout stalls after April 2026.
  • Poland, Brazil, and Texas expansions raise compliance complexity and operational failure risk.
  • Pharma sponsor pullbacks kill utilization; empty sites erase Care Access's decentralized advantage.

What makes Care Access unique

  • Care Access runs trials inside Walmart stores, closer to patients than traditional sites.
  • Its community screening model turns everyday health events into recruitment funnels for studies.
  • Global decentralization spans Brazil, Poland, and mobile infrastructure, not just U.S. clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations